Faculty Awards - Faculty of Health Sciences - McMaster University

160
PUBLICATIONS
WORSTER, A.
Publications
Worster A. A Role for Root Cause Analysis in
Laboratory Medicine. Labmedicine 2007; 38(12):709-
712.
Wathen CN, Jamieson E, Wilson M, Daly M, Worster A,
MacMillan HL and the McMaster University Violence
Against Women Research Group. Risk indicators to
identify intimate partner violence in the emergency
department. Open Medicine 2007; 1(2):113-22.
Richards D, Meshkat N, Chu J, Eva K, Worster A.
Emergency department patient compliance with follow-up
for outpatient exercise stress testing: a randomized
controlled trial. CJEM 2007 Nov; 9(6):435-40.
Daiter J, Teplin D, Varenbut M, Worster A, Raz B.
Diagnostic value of self-report of alcohol use in
patients enrolled in a methadone maintenance treatment
program (MMTP). J Addict Dis 2007; 26(3):87-92.
Rowe BH, Diner B, Camargo CA Jr, Worster A,
Colacone A, Wyer PC; Knowledge Translation -
Consensus Conference Theme Ib Members. Effective
synthesized / preappraised evidence formats in emergency
medicine and the use of supplemental knowledge
translation techniques. Acad Emerg Med 2007
Nov; 14(11):1023-9.
Varenbut M, Teplin D, Daiter J, Raz B, Worster A, Frank
N, Greenwald I, Konyer A, Emadi-Konjin P, Snider-Adler
M. Tampering by office-based methadone maintenance
patients with methadone take home privileges: a pilot
study.Harm Reduction Journal 2007; 4:15.
Daiter J, Teplin D, Varenbut, M, Worster A, Raz B.
Diagnostic Value of Self-Report of Alcohol Use in
Patients Enrolled in a Methadone Maintenance
Treatment Program (MMTP) Journal of Addictive
Diseases 2007; 26(3):87-92.
Worster A, Fernandes CM, Eva K, Upadhye S.
Predictive validity comparison of two five-level triage
acuity scales. Eur J Emerg Med 2007 Aug; 14(4) :188-
92.
Worster A, Sardo A, Eva K, Fernandes CM, Upadhye S.
Triage Tool Inter-rater Reliability: A Comparison of Live
Versus Paper Case Scenarios. J Emerg Nurs 2007 Aug;
33(4):319-23.
Worster A, Smith C, Silver S, Brown MD. Evidencebased
emergency medicine/critically appraised topic.
Thrombolytic therapy for submassive pulmonary
embolism? Ann Emerg Med 2007 Jul; 50(1):78-84.
Singh N, Arthur HM, Worster A, Iacobellis G, Sharma
AM. Emergency department equipment for obese
patients: perceptions of adequacy. J Adv Nurs 2007
Jul; 59(2):140-5.
Ferreira-Gonzalez I, Busse JW, Heels-Ansdell D,
Montori VM, Akl EA, Bryant DM, Alonso-Coello
P, Alonso J, Worster A, Upadhye S, Jaeschke R,
Schunemann HJ, Permanyer-Miralda G, Pacheco-
Huergo V, Domingo-Salvany A, Wu P, Mills EJ, Guyatt
GH. Problems with use of composite end points in
cardiovascular trials: systematic review of randomised
controlled trials. BMJ 2007 Apr 14; 334(7597):786.
Worster A, Fan J, Ismaila A. Understanding linear and
logistic regression analyses. CJEM 2007 Mar; 9(2):
111-3.
Upadhye S, Rivers EP, Worster A. Critical care response
teams: potential roles for emergency physicians. CJEM
2007 Jan; 9(1):34-7.
YOU, J.
Publications
Ko DT, Krumholz HM, Wang Y, Foody JM, Masoudi FA,
Havranek EP, You JJ, Alter DA, Stukel T, Newman AM,
Tu JV. Regional differences in process of care and
outcomes of older acute myocardial infarction patients
in the United States and Ontario, Canada. Circulation
2007; 115:196-203.
Wijeysundera HC, Vijayaraghavan R, Nallamothu BK,
Foody JM, Krumholz HM, Philips CO, You JJ, Kashani
A, Tu JV, Ko DT. Rescue angioplasty or repeat fibrinolysis
after failed fibrinolytic therapy for ST-segment myocardial
infarction: a meta-analysis of randomized trials.
J Am Coll Cardiol 2007; 30:422-30.
You JJ, Austin PC, Alter DA, Ko DT, Tu JV. Relation
between cardiac troponin I and mortality in acute
decompensated heart failure. Am Heart J 2007;
153:462-70.
You JJ, Woo A, Ko DT, Cameron DA, Mihailovic A,
Krahn M. Life expectancy gains and cost-effectiveness
of implantable cardioverter defibrillators for the primary
prevention of sudden cardiac death in patients
with hypertrophic cardiomyopathy. Am Heart J 2007;
154:899-907.
YUSUF, S.
Publications
Hawkins NM, Wang D, McMurray JJ, Pfeffer MA,
Swedberg K, Granger CB, Yusuf S, Pocock SJ,
Ostergren J, Michelson EL, Dunn FG. Prevalence and
prognostic implications of electrocardiographic left
ventricular hypertrophy in heart failure: evidence from
the CHARM programme. Heart 2007 Jan; 93(1):59-64.
Lewis EF, Lamas GA, O’Meara E, Granger CB, Dunlap
ME, McKelvie RS, Probstfield JL, Young JB, Michelson
EL, Halling K, Carlsson J, Olofsson B, McMurray JJ,
Yusuf S, Swedberg K, Pfeffer MA; for the CHARM
Investigators. Characterization of health-related quality
of life in heart failure patients with preserved versus
low ejection fraction in CHARM. Eur J Heart Fail. 2007;
9(1):83-91.
Merchant AT, Anand SS, Kelemen LE, Vuksan V, Jacobs
R, Davis B, Teo K, Yusuf S; SHARE and SHARE-AP
Investigators. Carbohydrate intake and HDL in a multiethnic
population. Am J Clin Nutr 2007; 85(1):225-30.
Joshi P, Islam I, Pais P, Reddy KS, Prabhakaran D,
Kazmi K, Pandey MR, Haque S, Mendis S, Yusuf S.
Why do South Asians develop myocardial infarction
at younger ages compared to other ethnic groups?
The INTERHEART South Asia Study. JAMA 2007;
297(3):286-94.
Diener HC, Sacco R, Yusuf S. Rationale, design and
baseline data of a randomized, double-blind, controlled
trial comparing two antithrombotic regimens (a
fixed-dose combination of extended-release dipyridamole
plus ASA with Clopidogrel) and telmisartan
versus placebo in patients with strokes: The Prevention
Regimen for effectively avoiding Second Strokes trial
(PRoFESS). Cerebrovasc Dis. 2007; 23(5-6):368-380.
Lanas F, Avezum A, Bautista LE, Diaz R, Luna M, Islam
S, Yusuf S for the INTERHEART Investigators in Latin
America. Risk factors for acute myocardial infarction in
Latin America. Circulation 2007; 115(9):1067-74.
Held C, Gerstein HC, Yusuf S, Zhao F, Hilbrich L,
Anderson C, Sleight P, Teo K, on behalf of the
ONTARGET/TRANSCEND Investigators. Glucose levels
predict hospitalization for congestive heart failure in
patients at high cardiovascular risk. Circulation 2007;
115(11):1371-5.
Gianni M, Bosch J, Pogue J, Probstfield J, Dagenais
G, Yusuf S, Lonn E. Effect of long-term ACE-inhibitor
therapy in elderly vascular disease patients. Eur Heart
J 2007 Jun; 28(11):1277-8.
Razak F, Anand SS, Shannon H, Vuksan V, Davis B,
Jacobs R, Teo KK, McQueen M, Yusuf S. Defining obesity
cut points in a multiethnic population. Circulation
2007 Apr 24; 115(16):2111-8.
Keltai M, Tonelli M, Mann JF, Sitkei E, Lewis BS,
Hawken S, Mehta SR, Yusuf S; for the Clopidogrel in
Unstable angina to prevent Recurrent Events (CURE)
trial investigators. Renal function and outcomes in
acute coronary syndrome: impact of clopidogrel. Eur J
Cardiovasc Prev Rehabil 2007; 14(2):312-18.
Hilbrich L, Truelsen T, Yusuf S. Stroke and cardiovascular
diseases: the need for a global approach for
prevention and drug development. Int J Stroke 2007;
2:104-8.
O’Meara E, Clayton T, McEntegart MB, McMurray
JJV, Pina I, Granger CB, Ostergren J, Michelson EL,
Solomon SD, Pocock S, Yusuf S, Swedberg K, Pfeffer
MA. Sex differences in clinical characteristics and
prognosis in a broad spectrum of patients with heart
failure – results of the Candesartan in Heart failure:
Assessment of Reduction in Mortality and morbidity
Program (CHARM). Circulation 2007; 115:3111-20.
Bohm M, Baumhakel M, Probstfield JL, Schmieder R,
Yusuf S, Zhao F, Koon T, on Behalf of the ONTARGET/
TRANSCEND-Investigators. Sexual function, satisfaction,
and association of erectile dysfunction with
cardiovascular disease and risk factors in cardiovascular
high-risk patients: Substudy of the ONgoing
Telmisartan Alone and in Combination with Ramipril
Global Endpoint Trial/Telmisartan Randomized
AssessmeNT Study in ACE-INtolerant Subjects with
Cardiovascular Disease (ONTARGET/TRANSCEND). Am
Heart J. 2007; 154(1):94-101.
Peters RJG, Mehta S, Yusuf S. Acute coronary syndromes
without ST segment elevation. BMJ 2007;
334:1265-69.
Felker GM, Allen LA, Pocock SJ, Shaw LK, McMurray
JJV, Pfeffer MA, Swedberg K, Wang D, Yusuf S,
Michelson EL, Granger CB, for the CHARM investiga-
tors. Red cell distribution width as a novel prognostic
marker in heart failure: data from the CHARM Program
and Duke Databank. J Am Coll Cardiol 2007; 50(1):40-7.
The Warfarin Antiplatelet Vascular Evaluation Trial
Investigators. Oral anticoagulant and antiplatelet therapy
and peripheral arterial disease. N Engl J Med 2007;
357(3):217-227.
Kenchaiah S, Pocock SJ, Wang D, Finn PV, Zornoff
LAM, Skali H, Pfeffer MA, Yusuf S, Swedberg K,
Michelson EL, Granger CB, McMurray JJV, Solomon
SD for the CHARM Investigators. Body mass index
and prognosis in patients with chronic heart failure:
Insights from the Candesartan in Heart failure:
Assessment of Reduction in Mortality and morbidity
(CHARM) program. Circulation 2007; 116:627-36.
Connolly SJ, Eikelboom J, O’Donnell M, Pogue J, Yusuf
S. Challenges of establishing new antithrombotic therapies
in atrial fibrillation. Circulation 2007; 116:449-455.
Wittes J, Barrett-Connor E, Braunwald E, Chesney M,
Cohen HJ, Demets D, Dunn L, Dwyer J, Heaney RP,
Vogel V, Walters L, Yusuf S. Monitoring the randomized
trials of the Women’s Health Initiative: the experience
of the Data and Safety Monitoring Board. Clin Trials
2007; 4(3):218-34.
Wang J, Cao H, Ban MR, Kennedy BA, Zhu S, Anand S,
Yusuf S, Pollex RL, Hegele RA. Resequencing genomic
DNA of patients with severe hypertriglyceridemia
(MIM 144650). Arterioscler Thromb Vasc Biol 2007 Nov;
27(11):2450-5.
Salehian O, Lonn E, Dagenais G, Mathew J, Healey J,
Pogue J, Yusuf S. Impact of ramipril on the incidence
of atrial fibrillation: results of the Heart Outcomes
Prevention Evaluation study. Am Heart J 2007;
154(3):448-53.
Solomon SD, Dobson J, Pocock S, Skali H, McMurray
JJ, Granger CB, Yusuf S, Swedberg K, Young JB,
Michelson EL, Pfeffer MA; Candesartan in Heart failure:
Assessment of Reduction in Mortality and morbidity
(CHARM) Investigators. Circulation 2007 Sep 25;
116(13):1482-7.
Fox KA, Bassand JP, Mehta SR, Wallentin L, Theroux P,
Piegas LS, Valentin V, Moccetti T, Chrolavicius S, Afzal
R, Yusuf S; OASIS 5 Investigators. Influence of renal
function on the efficacy and safety of fondaparinux
relative to enoxaparin in non ST-segment elevation
acute coronary syndromes. Ann Intern Med. 2007 Sep
4; 147(5):304-10.
Friedewald VE, Bates ER, Granger CB, Yusuf S, Roberts
WC. The Editor’s Roundtable: arterial thrombosis and
acute coronary syndromes. Am J Cardiol. 2007 Sep 15;
100(6):974-8.
Alegria JR, Miller TD, Gibbons RJ, Yi QL, Yusuf S;
Collaborative Organization of RheothRx Evaluation
(CORE) Trial Investigators. Infarct size, ejection fraction,
and mortality in diabetic patients with acute myocardial
infarction treated with thrombolytic therapy.
Am Heart J. 2007 Oct; 154(4):743-50.
Yusuf S, Fallen E, Harrington RA, Guyton RA. Clinical
Decisions: Management of stable coronary disease. N